Explore evidence

43.6 %The prevalence of BCP double substitution G1764A was 43.6% among sequenced BCP/PC gene amplicons.

Nigeriahépatite Bpublished 2023Viruseseurope_pmcdocument of 6 observationsDOI 10.3390/v15112188

7.2 %In 2019, 0.2 million (7.2%) of approximately 2.8 million pregnant women who received antenatal care in Nigeria were screened for hepatitis B virus (HBV).

Nigeriahépatite Bobserved 2019published 2021International journal of STD & AIDSPubMeddocument of 10 observations

40 %In this study, the classical precore G1899A variant was identified in 17 out of 42 (40%) asymptomatic carriers.

Nigeriahépatite Bpublished 2025Viruseseurope_pmcdocument of 6 observations

12.6 %Among pregnant women in Jos, Nigeria, the prevalence of hepatitis B virus (HBV) was 12.6% among those with human immunodeficiency virus (HIV) and 7.2% among those without HIV, during the period from 1 November 2017 to 30 April 2018.

Nigeriahépatite B · VIH/sidaobserved 1 November 2017 to 30 April 2018published 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 3 observations

6 %The prevalence of anti-HBe among 150 PLHIV in the study was 6.0%.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 15 observations

7 %The prevalence of HBV among adolescents aged 10 to 19 years seeking healthcare services at the Federal Teaching Hospital, Birnin Kebbi, Nigeria, was 7.0% between January and June 2023.

Nigeriahépatite Bobserved January and June 2023published 2025African journal of reproductive healthPubMeddocument of 4 observations

Co-infected patients demonstrated worse clinical outcomes, such as elevated liver enzymes, decompensated cirrhosis, and higher rates of hepatocellular carcinoma.

Nigeriahépatite B · hepatitis D viruspublished 2024VirusesPubMeddocument of 7 observations

33.3 %The classical PC mutant variant G1896A was observed in 33.3% of sequenced BCP/PC gene amplicons.

Nigeriahépatite Bpublished 2023Viruseseurope_pmcdocument of 6 observationsDOI 10.3390/v15112188

84 individualsAmong those tested for hepatitis B in the medical outreach in Durum community, Bauchi State, Nigeria, 84 (42%) had positive results.

Nigeriahépatite Bobserved 2023published 2023West African journal of medicinePubMeddocument of 11 observations

1 %Of the 200 participants, 2 (1.0%) had both HBV and syphilis infections.

Nigeriahépatite B · syphilispublished 2022Journal of immunoassay & immunochemistryPubMeddocument of 5 observations

76.5 %76.5% of the BCP/PC gene amplicons were successfully sequenced from HBV-DNA-positive samples.

Nigeriahépatite Bpublished 2023Viruseseurope_pmcdocument of 6 observationsDOI 10.3390/v15112188

0.14 %Among 2775 pregnant women in Nigeria, the seroprevalence of triplex infection with HIV, HBV, and HCV was 0.14%.

Nigeriahépatite B · hépatite C · VIH/sidapublished 2025Antiviral therapyPubMeddocument of 7 observations

32.2 %Prevalence of HBsAg among liver diseases patients in Osun State was 32.2%.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 4 observations

72 %Among 50 HBsAg-positive samples, 72.0% (36/50) were positive for HBV DNA.

Nigeriahépatite B · VIH/sidaobserved June 2017 to August 2017published 2021Virology journalPubMeddocument of 6 observations

9.9 %The hepatitis B prevalence in conflict zones in Nigeria was 9.9%.

Nigeriahépatite Bobserved 2018published 2021Annals of global healthPubMeddocument of 12 observations

8.6 %Hepatitis B had a prevalence of 8.6% in 2021 among blood donors in Osun State.

Nigeriahépatite Bobserved 2021published 2025BMC infectious diseasesPubMeddocument of 17 observations

6.2 %The prevalence of hepatitis B virus (HBV) among antenatal women at the 68 Nigerian Army Reference Hospital in Lagos was 6.2%.

Nigeriahépatite Bpublished 2022West African journal of medicinePubMeddocument of 6 observations

7.51 ×10⁹/LNon-SCD individuals infected with HBV had significantly higher WBC (7.51 ± 5.8 ×10⁹/L) compared to uninfected individuals (6.1 ± 3.4 ×10⁹/L).

Nigeriahépatite Bpublished 2021West African journal of medicineeurope_pmcdocument of 4 observations

0.22 %Among 2775 pregnant women in Nigeria, the seroprevalence of HIV-HBV dual infection was 0.22%.

Nigeriahépatite B · VIH/sidapublished 2025Antiviral therapyPubMeddocument of 7 observations

2 %HDV prevalence among HBV-infected individuals in Nigeria ranged from 2.0% to 31.6%.

Nigeriahépatite B · hepatitis D viruspublished 2024VirusesPubMeddocument of 7 observations

50 %The frequency of HBeAb was 50% among the HBV mono-infected cohort.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 11 observations

2,000,000,000 peopleHepatitis B virus infects about 2 billion people globally.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 11 observations

0.47 %Among 2775 pregnant women in Nigeria, the seroprevalence of dual infection with HIV, HBV, and HCV was 0.47%.

Nigeriahépatite B · hépatite C · VIH/sidapublished 2025Antiviral therapyPubMeddocument of 7 observations

7.3 %The hepatitis B prevalence in non-conflict zones in Nigeria was 7.3%.

Nigeriahépatite Bobserved 2018published 2021Annals of global healthPubMeddocument of 12 observations

0.64 %The prevalence of HIV/HBV/HCV triple co-infection among HIV-positive patients attending three major hospitals in the Federal Capital Territory, Nigeria was 0.64%.

Nigeriahépatite B · hépatite C · VIH/sidaobserved 2019published 2020Journal of immunoassay & immunochemistryPubMeddocument of 9 observations